| Dr Mark Edward Swetz, MD | |
|
3065 Southwestern Blvd, Suite 206, Orchard Park, NY 14127-1239 | |
| (716) 674-1414 | |
| (716) 674-1473 |
| Full Name | Dr Mark Edward Swetz |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 3065 Southwestern Blvd, Orchard Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013918879 | NPI | - | NPPES |
| P00175635 | Other | NY | RAILROAD MEDICARE |
| 3787523 | Other | NY | AETNA |
| 00010176002 | Other | NY | UNIVERA |
| 608008800 | Other | NY | WC U.S. DEPT. OF LABOR |
| 5904267 | Other | NY | GHI |
| 352240675 | Other | NY | UNITED HEALTHCARE |
| 000523769002 | Other | BC BS OF WNY | |
| 0107477 | Other | IHA | |
| 194104-6 | Other | NY | WORKERS COMP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 194104 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care (amherst) | Amherst, NY | Home health agency |
| Mcauley Seton Home Care Corp Chha | Buffalo, NY | Home health agency |
| Mercy Hospital Of Buffalo | Buffalo, NY | Hospital |
| Sisters Of Charity Hospital | Buffalo, NY | Hospital |
| Olean General Hospital | Olean, NY | Hospital |
| Entity Name | Mark E Swetz Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265585392 PECOS PAC ID: 8628035425 Enrollment ID: O20041214000133 |
News Archive
Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Edward Swetz, MD 3065 Southwestern Blvd, Suite 206, Orchard Park, NY 14127-1239 Ph: (716) 674-1414 | Dr Mark Edward Swetz, MD 3065 Southwestern Blvd, Suite 206, Orchard Park, NY 14127-1239 Ph: (716) 674-1414 |
News Archive
Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration.
The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.
› Verified 5 days ago
Mrs. Suzanne Lignos, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 24 Carrow St, Orchard Park, NY 14127 Phone: 716-662-3443 Fax: 716-662-8282 | |
Thomas I Dilamarter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3045 Southwestern Blvd, Suite 108, Orchard Park, NY 14127 Phone: 716-260-1593 Fax: 716-771-3903 | |
Ms. Amy Renee Pohlman, P. A. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3670 S Benzing Rd, Orchard Park, NY 14127 Phone: 716-662-5357 Fax: 716-662-2774 | |
Dr. Richard Joseph Ruh, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3670 S Benzing Rd, Orchard Park, NY 14127 Phone: 716-662-5357 Fax: 716-662-2774 | |
Dr. Vincent Olin Carfagna, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6300 Powers Rd, Orchard Park, NY 14127 Phone: 716-667-3200 Fax: 716-667-3120 | |
Mary Katherine Kolbert, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3900 N Buffalo St, Orchard Park, NY 14127 Phone: 716-630-1143 Fax: 716-817-1766 |